Chinese Pla General Hospital

This early-stage trial is testing a personalized cancer vaccine made from a patient's own immune cells. The cells are engineered to target two specific markers found on some advanced solid tumors and are given alongside standard immunotherapy drugs. The main goals are to see if t…

This trial is testing a new method for stem cell transplants in people with severe aplastic anemia, a serious blood disorder. Researchers are comparing a new way of preparing stem cells from umbilical cords (grown in a 3D, low-oxygen environment) against the standard method. The …

This study is testing if a special monitor can help doctors decide the safest time to remove a patient's breathing tube after surgery. The monitor gives a single score based on breathing rate, oxygen levels, and heart rate. Researchers will compare patients whose tube removal is …

This study is testing whether a new drug combination (venetoclax + CACAG) works better and is safer than the current standard chemotherapy ('3+7' regimen) for adults newly diagnosed with intermediate- or high-risk acute myeloid leukemia (AML). It will involve 160 participants who…

This study is testing whether a newly discovered type of cell, called a 'showering cell,' can help doctors diagnose aspiration pneumonia. Researchers are comparing lung fluid samples from 94 hospitalized adults with and without this type of pneumonia to see if counting these cell…

This study is observing how well the medication rimegepant works for treating migraine attacks in everyday life. It will follow 3000 adults in China for up to a year to see how quickly it relieves pain, how satisfied people are with the relief, and if it helps them return to norm…

This study aims to create a tool that helps doctors predict which people with psoriasis are more likely to develop insulin resistance, a silent condition that raises the risk of diabetes and heart disease. Researchers will use existing medical records from over 1,200 patients to …